Two Promising Drug Therapies For Pulmonary Fibrosis

Two studies have found that two investigational drugs -- pirfenidone and nintedanib -- had positive effects on patients with idiopathic pulmonary fibrosis (IPF), such as slowing the loss of lung function, reducing mortality, and reducing acute exacerbations.